Nanding, Zuilybeth S.
HRN: 18-60-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CEFUROXIME 750MG (VIAL)
07/17/2022
07/24/2022
IV
500mg
Q8h
PCAP C UTI
Waiting Final Action
09/28/2022
CEFUROXIME 750MG (VIAL)
09/28/2022
10/05/2022
IV
390 Mg
Q8
AGE
Waiting Final Action